Deep Dive In Vitiligo podcast

Why Is There No Cure for Vitiligo? (Ep. 80)

0:00
20:16
Reculer de 15 secondes
Avancer de 15 secondes

A paused drug program. A reasonable suspicion. Then the question under it: why is there still no cure?

In this episode, Yan Valle argues there is no hidden pill in a glass tower. Companies are not charities, and they are not sitting on a cure because a chronic treatment pays better. The harder account is ordinary. Academia funds what it can publish. Biotech bets on the next round. Pharma keeps what can survive the regulators and the market. Insurers pay for this year’s budget. Patients inherit the sum.

A program can die before anyone knows if the biology was right — a bet on another bet, ten years out, before the casino is built. Early treatment of active vitiligo sounds obvious, and still loses to step therapy and a planning horizon shorter than a child’s year. The price on the receipt was not set by one hand. And “they buried the cure” is easier to air than a system with no villain.

Misconduct is real. This is not a defense of it. But systems before conspiracy is usually the better place to start.

The full essay is on the VRF site. Ten minutes. A double coffee is welcome.

D'autres épisodes de "Deep Dive In Vitiligo"